Insulin-Like Growth Factor I Deficiency
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Derangements of GH peak were detected in 61.5% of studied patients while IGF-1 deficiency was detected in 71% of the population.
|
31527400 |
2019 |
Insulin-Like Growth Factor I Deficiency
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Additionally, we found that the inability of growth hormone to restore the IGF-1 deficiency was associated with suppressed expression and signaling of growth hormone receptor in liver.
|
31791247 |
2019 |
Insulin-Like Growth Factor I Deficiency
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Two patients showed IGF‑1 deficiency with normal growth hormone level.
|
31115572 |
2019 |
Insulin-Like Growth Factor I Deficiency
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Primary Insulin like growth factor 1 (IGF - 1) deficiency in short stature can present with normal or elevated growth hormone (GH) production.
|
30197657 |
2018 |
Insulin-Like Growth Factor I Deficiency
|
0.100 |
Biomarker
|
disease |
BEFREE |
Pre-treatment growth and IGF-I deficiency as main predictors of response to growth hormone therapy in neural models.
|
29242356 |
2018 |
Insulin-Like Growth Factor I Deficiency
|
0.100 |
Biomarker
|
disease |
BEFREE |
A focus on reversible mechanisms identified Insulin-like growth factor (IGF1) deficiency with inadequate compensation by Growth hormone-releasing hormone (GHRH) and Growth hormone (GH), underappreciated findings in <i>ARID1B</i> patients.
|
28695822 |
2017 |
Insulin-Like Growth Factor I Deficiency
|
0.100 |
Biomarker
|
disease |
BEFREE |
A 2-year longitudinal study was performed to estimate the prevalence of GH and/or IGF-1 deficiency in clinically isolated syndrome (CIS) patients and their correlation with conversion to MS in IFN treated patients.
|
27982500 |
2017 |
Insulin-Like Growth Factor I Deficiency
|
0.100 |
Biomarker
|
disease |
BEFREE |
It is well documented that the cardiovascular system is an important target organ for growth hormone (GH) and insulin-like growth factor (IGF)-1 in humans, and GH /IGF-1 deficiency significantly increases the risk for cardiovascular diseases (CVD).
|
29375617 |
2017 |
Insulin-Like Growth Factor I Deficiency
|
0.100 |
Biomarker
|
disease |
BEFREE |
Our study describes the first case of DBQD2 resulting from compound heterozygous XYLT1 mutation, expands the mutational spectrum of the disease and provides evidence that the severe growth retardation and microsomia observed in DBQD2 patients may result not only from the skeletal dysplasia itself but also from GH and IGF-1 deficiency.
|
27030147 |
2016 |
Insulin-Like Growth Factor I Deficiency
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
The critical importance of STAT5B in human IGF-I production was confirmed with the identification of the first homozygous, autosomal recessive, STAT5B mutation in a young female patient who phenotypically resembled patients with classical growth hormone insensitivity (GHI) syndrome (Laron syndrome) due to mutations in the GHR gene, presenting with severe postnatal growth failure and marked IGF-I deficiency.
|
26703237 |
2016 |
Insulin-Like Growth Factor I Deficiency
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Individuals with Laron syndrome carry mutations in the GHR gene resulting in severe congenital IGF-1 deficiency and elevated GH serum levels leading to short stature as well as perturbed lipid and glucose metabolism.
|
26510874 |
2015 |
Insulin-Like Growth Factor I Deficiency
|
0.100 |
Biomarker
|
disease |
BEFREE |
Also, mouse models with developmental GH/IGF-I deficiency/resistance are less susceptible to genetic- or chemical-induced mammary tumorigenesis.
|
25085903 |
2014 |
Insulin-Like Growth Factor I Deficiency
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Mutations in the human growth hormone receptor gene (GHR) are the most common cause of growth hormone insensitivity (GHI) syndrome and insulin-like growth factor (IGF-1) deficiency.
|
24296660 |
2013 |
Insulin-Like Growth Factor I Deficiency
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Long-term auxological and pubertal outcome of patients with hereditary insulin-like growth factor-I deficiency (Laron and growth hormone-gene deletion syndrome) treated with recombinant human insulin-like growth factor-I.
|
20543555 |
2011 |
Insulin-Like Growth Factor I Deficiency
|
0.100 |
Biomarker
|
disease |
BEFREE |
Although IGFD can develop at any level of the GH-releasing hormone (GHRH)-GH-IGF axis, a differentiation should be made between GHD (absent to low GH in circulation) and IGFD (normal to high GH in circulation).
|
21274339 |
2010 |
Insulin-Like Growth Factor I Deficiency
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Insulin-like growth factor-I deficiency in children with growth hormone insensitivity: current and future treatment options.
|
19627167 |
2009 |
Insulin-Like Growth Factor I Deficiency
|
0.100 |
Biomarker
|
disease |
BEFREE |
Growth hormone (GH) insensitivity and insulin-like growth factor-I deficiency in Inuit subjects and an Ecuadorian cohort: functional studies of two codon 180 GH receptor gene mutations.
|
18073295 |
2008 |
Insulin-Like Growth Factor I Deficiency
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
There are currently four known genetic causes of GH insensitivity/primary IGF deficiency: GH receptor deficiency (also known as Laron syndrome or GH insensitivity syndrome), IGF-1 deficiency, signal transducer and activator of transcription 5b (STAT5b) deficiency and acid labile subunit (ALS) deficiency.
|
17986822 |
2007 |
Insulin-Like Growth Factor I Deficiency
|
0.100 |
Biomarker
|
disease |
BEFREE |
Since low dose injection of growth hormone (GH) normalized the response to exogenous insulin in RPTPsigma-/- mice, we propose that the insulin hypersensitivity observed in RPTPsigma-/- mice is secondary to their neuroendocrine dysplasia and GH/IGF-1 deficiency.
|
16998539 |
2006 |
Insulin-Like Growth Factor I Deficiency
|
0.100 |
Biomarker
|
disease |
BEFREE |
Partial growth hormone (GH) insensitivity can be defined as the clinical and biochemical features of IGF-I deficiency without GH deficiency and in the absence of the dysmorphic features of Laron syndrome.
|
10698589 |
1999 |